Infographic: FDA gains authority to prescribe less, but opioid prescriptions decreasing

By Maggie Lynch

- Last updated on GMT

(Image: Getty/	SARINYAPINNGAM)
(Image: Getty/ SARINYAPINNGAM)

Related tags Opioid Opioid epidemic overdose

President Donald Trump signed the SUPPORT Act granting the FDA additional authority to combat the opioid epidemic, but a pain management CRO argues that opioid addiction isn't the only crisis.

After the SUPPORT Act was signed into legislation, Lynn Webster, VP of Scientific Affairs and Neuroscience at PRA Health Sciences, a clinical contract research organization (CRO), stated the new legislation has its shortcomings. 

One of the shortcomings, according to Webster, is that despite a continual decline in opioid prescription over the past several years, the legislation grants the FDA the ability to reduce the overall number of opioids in circulation. 

"There is a disconnect between the ​amount of prescribed opioids and the number of drug overdoses,"​ said Webster who believes the root cause of the drug crisis is complex and was not fully addressed by the legislation. 

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

PatSnap | 15-Jun-2022 | Technical / White Paper

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us

Products

View more

Webinars